Development of appropriate fatty acid formulations to raise the contractility of constructed myocardial tissues.
Regen Ther
; 21: 413-423, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36248630
ATP, Adenosine triphosphate; Cardiomyocyte; Culture medium; DMEM, Dulbecco's Modified Eagle's Medium; DMEM-HG, DMEM containing 4500 mg/L glucose; DMEM-Hanks, DMEM containing Hanks' salts; DMEM-LG, DMEM containing 1000 mg/L glucose; Energy production; FA-free, Medium without fatty acids; FA-mix, Medium containing a mixture of fatty acids; FAD, Flavin adenine dinucleotide; FBS, Fetal bovine serum; Fatty acid; HBSS, Hanks' Balanced Salt Solution; NAD, Nicotinamide adenine dinucleotide; OCR, Oxygen consumption rate; P/S, Penicillin-streptomycin; TR-F, Time-resolved fluorescence; hiPSC-CM, Human induced pluripotent stem cell-derived cardiomyocyte; rat-CM, Neonatal rat primary cardiomyocyte; ß-oxidation
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Regen Ther
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Japão
País de publicação:
Holanda